NPI: 1780612713 · DURHAM, NC 27705 · Family Medicine Physician · NPI assigned 06/29/2006
Authorized official ROBERTS, JENNIFER controls 20+ related entities in our dataset. Read more
| Authorized Official | ROBERTS, JENNIFER (DIRECTOR FINANCE) |
| NPI Enumeration Date | 06/29/2006 |
Other providers sharing the same authorized official: ROBERTS, JENNIFER
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 19,635 | $985K |
| 2019 | 17,345 | $1.12M |
| 2020 | 12,129 | $781K |
| 2021 | 42,052 | $1.70M |
| 2022 | 68,645 | $2.52M |
| 2023 | 74,283 | $2.37M |
| 2024 | 69,650 | $2.04M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 82,199 | 73,257 | $6.40M |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 48,155 | 40,628 | $2.72M |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 16,864 | 13,735 | $743K |
| 99199 | Unlisted special service, procedure or report | 116,423 | 52,305 | $659K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 5,752 | 5,140 | $354K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 8,567 | 7,667 | $229K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 4,929 | 4,669 | $123K |
| 99215 | Prolong outpt/office vis | 674 | 583 | $77K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 926 | 733 | $76K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 4,206 | 3,928 | $52K |
| 81003 | 8,565 | 7,475 | $17K | |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 122 | 112 | $16K |
| 87634 | 347 | 276 | $9K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 209 | 158 | $7K |
| 71046 | Radiologic examination, chest; 2 views | 526 | 492 | $7K |
| 81025 | 1,087 | 915 | $7K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 416 | 380 | $4K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 86 | 58 | $4K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 310 | 249 | $4K |
| 87210 | 991 | 846 | $3K | |
| 36415 | Collection of venous blood by venipuncture | 1,372 | 1,192 | $3K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 87 | 59 | $1K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 29 | 12 | $917.94 |
| 87807 | 63 | 37 | $695.74 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 120 | 111 | $624.04 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 551 | 459 | $520.41 |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 57 | 52 | $289.91 |
| 80048 | Basic metabolic panel (calcium, ionized) | 27 | 26 | $100.50 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 13 | 12 | $38.78 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 66 | 59 | $2.27 |